DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,748,017 | +9.8% | 27,198 | +6.2% | 0.14% | +10.5% |
| Q2 2023 | $6,146,527 | -14.8% | 25,610 | -10.5% | 0.12% | -25.7% |
| Q1 2023 | $7,210,751 | -5.1% | 28,610 | -0.0% | 0.17% | -21.6% |
| Q4 2022 | $7,596,526 | +1.5% | 28,622 | -1.2% | 0.21% | +3.9% |
| Q3 2022 | $7,483,000 | +99.1% | 28,970 | +95.4% | 0.20% | +79.8% |
| Q2 2022 | $3,759,000 | -33.4% | 14,827 | -23.0% | 0.11% | -15.6% |
| Q1 2022 | $5,647,000 | -6.5% | 19,251 | +4.9% | 0.14% | -3.6% |
| Q4 2021 | $6,039,000 | +14.7% | 18,355 | +6.2% | 0.14% | 0.0% |
| Q3 2021 | $5,263,000 | +24.4% | 17,289 | +9.7% | 0.14% | +12.9% |
| Q2 2021 | $4,230,000 | +39.6% | 15,762 | +17.0% | 0.12% | -0.8% |
| Q1 2021 | $3,031,000 | +12.0% | 13,468 | +7.1% | 0.12% | -14.4% |
| Q3 2020 | $2,707,000 | +19.5% | 12,573 | -1.8% | 0.15% | -0.7% |
| Q2 2020 | $2,265,000 | +20.7% | 12,807 | -5.6% | 0.15% | -2.6% |
| Q1 2020 | $1,877,000 | -2.7% | 13,566 | +7.9% | 0.15% | -10.7% |
| Q4 2019 | $1,929,000 | – | 12,571 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |